Spironolactone Structural Formula (Image 01)
Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 42292-017
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 42292-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Hydrochlorothiazide Structural Formula (Image 02)
Spironolactone & Hydrochlorothiazide 25 mg/25 mg Tablets Unit Carton Label (Image 03)
Spironolactone and Hydrochlorothiazide Tablets, USP are a medication containing 25mg/25mg of Spironolactone and Hydrochlorothiazide respectively. They are supplied in a pack of 100 tablets, and the usual adult dosage is contained in the prescribing information that comes with the tablets. The medication should be stored at 20°C to 25°C and protected from light. Mylan Pharmaceuticals Inc. in Morgantown, WY, USA manufactures the medication.*
Serialized Unit Carton (Image 04)
This text is a set of cautionary statements related to a drug packaging. It mentions that the packaging is not intended for use by children and is for institutional use only. It also provides instructions to keep the drugs out of the reach of children and highlights that the container offers light-resistance. Additionally, it indicates that the lot number and expiration date can be found on the window. The name of the drug company appears to be Mylan, located in Rockford, USA. The text does not provide any information on the name or type of drug.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
